Heart arrhythmia specialist company, Biosense Webster, Inc., has enrolled and treated the first patient in Europe to its SHINE clinical study. Johnson and Johnson company Biosense Webster says its multicenter study will evaluate the its next generation multi-electrode radiofrequency (RF)...
Corin Group has launched its new Unity Knee™ with EquiBalance™ instrumentation at this year's...read the full article >
The First-in-Man (FIM) study of SELUTION™, Med Alliance’s novel sirolimus-coated balloon has...read the full article >
The U.S. FDA has approved an Investigational Device Exemption for the CardiAMP Chronic Myocardial...read the full article >